Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032
© Sperandio et al; licensee BioMed Central Ltd. 2010
Received: 23 November 2009
Accepted: 24 April 2010
Published: 24 April 2010
MFN1032 is a clinical Pseudomonas fluorescens strain able to grow at 37°C. MFN1032 cells induce necrosis and apoptosis in rat glial cells at this temperature. This strain displays secretion-mediated hemolytic activity involving phospholipase C and cyclolipopeptides. Under laboratory conditions, this activity is not expressed at 37°C. This activity is tightly regulated and is subject to phase variation.
We found that MFN1032 displays a cell-associated hemolytic activity distinct from the secreted hemolytic activity. Cell-associated hemolysis was expressed at 37°C and was only detected in vitro in mid log growth phase in the presence of erythrocytes. We studied the regulation of this activity in the wild-type strain and in a mutant defective in the Gac two-component pathway. GacS/GacA is a negative regulator of this activity. In contrast to the Pseudomonas fluorescens strains PfO-1 and Pf5, whose genomes have been sequenced, the MFN1032 strain has the type III secretion-like genes hrc RST belonging to the hrpU operon. We showed that disruption of this operon abolished cell-associated hemolytic activity. This activity was not detected in P.fluorescens strains carrying similar hrc genes, as for the P. fluorescens psychrotrophic strain MF37.
To our knowledge this the first demonstration of cell-associated hemolytic activity of a clinical strain of Pseudomonas fluorescens. Moreover, this activity seems to be related to a functional hrpU operon and is independent of biosurfactant production. Precise link between a functional hrpU operon and cell-associated hemolytic activity remains to be elucidated.
Pseudomonas fluorescens is a highly heterogeneous species, as shown the extensive literature on the taxonomy and phylogeny of this species [1–4]. These studies include saprophytic, rhizopheric and phytopathogenic strains of P. fluorescens, illustrating the ubiquity of this species. Most studies describe P. fluorescens as a psychrotrophic bacterium unable to grow at temperatures greater than 32°C and therefore as an avirulent bacterium in humans. Nevertheless, previous studies of the infectious potential of P. fluorescens have demonstrated that the rifampicin spontaneous mutant MF37  derived from the environmental psychrotrophic strain MF0  can bind specifically to the surface of neurons and glial cells . This adhesion to the host cell is associated with the induction of apoptosis and necrosis in glial cells . Lipopolysaccharides (LPS) produced or released by P. fluorescens have a clear role in cytotoxicity, but other factors released at the same time during adhesion also seem to be essential for the virulence of this bacterium . Thus the various enzymes secreted by this species may also be considered as potential high virulence factors .
We recently demonstrated that the clinical strain MFN1032 is a Pseudomonas fluorescens sensus stricto Biovar1 strain able to grow at 37°C . This strain has hemolytic activity mediated by secreted factors, similar to the hemolytic activity seen for the opportunistic pathogen Pseudomonas aeruginosa, involving phospholipase C (PlcC) and biosurfactant . Under specific conditions, MFN1032 forms colonies of phenotypic variants, which are defective in secreted hemolysis. Spontaneous mutations of the genes encoding the two-component regulatory system GacS/GacA have been identified as the cause of phenotypic variation in one such group of variants. We hypothesized that phenotypic variation increases the virulence potential of this strain. However these group variants (group 1 variants) do not produce secondary metabolites and have impaired biofilm formation . Then, these results suggested that virulence of MFN1032 is not dependent solely on secreted factors or LPS and thus must involve other factors.
Some bacterial virulence factors are only expressed in the presence of eukaryotic cells. This is the case of the type III secretion system (TTSS), one of the most frequently described contact dependent secretion systems in Pseudomonas. TTSSs are found in many Gram-negative pathogens. They allow the direct translocation of bacterial effector proteins into the cytoplasm of eukaryotic host cells. P. aeruginosa uses the TTSS to translocate four effector proteins (ExoS, ExoT, ExoU, and ExoY) with antihost properties . The P. aeruginosa TTSS consists of nearly 40 genes, regulated in a coordinated manner and encoding structural components of the secretion and translocation machinery, effectors proteins, and regulatory factors . Transcription of the TTSS is induced under calcium-limited growth conditions or following intimate contact of P. aeruginosa with eukaryotic host cells . Pseudomonas syringae pv. tomato DC3000 is a phytopathogenic bacterium that harbors a gene cluster hrp (for hypersensitive reaction and pathogenicity). This hrp cluster is essential for pathogenicity in susceptible plants and for the ability to elicit the hypersensitive reaction in nonhosts or resistant cultivars of host plants . hrp genes are expressed in planta or in media mimicking plant apoptotic conditions . Sequence analyses have uncovered a shared subset of nine hrp genes that were renamed hrc (for hrp and conserved) and that encode proteins homologous to Yersinia ysc gene products . The existence of these genes suggests evolutionary conservation of molecular mechanisms of pathogenicity used by both mammalian and phytopathogenic bacteria .
In the present study, we describe the detection of cell-associated hemolytic activity of P. fluorescens MFN1032 in contact with sheep erythrocytes. This hemolytic activity was compared with the hemolytic activity of other P. fluorescens strains: a spontaneous MFN1032 gac A mutant and the opportunistic pathogen Pseudomonas aeruginosa CHA . Cell-associated hemolytic activity and its regulation were compared with the activity and regulation of the previously described secreted hemolytic activity of MFN1032. We then looked for hrc genes in our strain and determined their role in the cell-associated hemolytic activity of MFN1032, using hrpU operon disruption mutant.
MFN1032 displays cell-associated hemolytic activity
Hemolytic activity of Pseudomonas fluorescens biovar I MFN1032 and Pseudomonas aeruginosa CHA (positive control for TTSS-mediated hemolysis) was measured by the technique employed by Dacheux , adapted as described in methods.
Lysis of RBCs is caused by a pore-forming toxin from MFN1032
MFN1032 cell-associated hemolytic activity is higher than in other Pseudomonas fluorescens strains
We tested the hemolytic activity of MFN1032, MFY162 (a clinical isolate of Pseudomonas fluorescens Biovar I), MFY161 and MFY163 (clinical isolates of Pseudomonas mosselli) , MF37 (Pseudomonas fluorescens biovar V, derived from a psychrotrophic environmental strain) and C7R12 (a psychrotrophic rhizospheric strain) cells at 28 and 37°C.
The hemolytic activities of MFN1032, MFY162 and MFY161, were maximal at their optimal growth temperature (28°C for MFN1032 and MFY162, 37°C for MFY 161). The hemolytic activity of the strain MFY163 was the same at 28°C and 37°C.
Involvement of the Gac two-component system on cell-associated hemolytic activity
The non-transformed V1 strain displayed enhanced hemolytic activity (160% lysis), using MFN1032 as a reference value (100%). Introduction of a gacA gene in V1 cells by electroporation with pMP5565 restored wild-type hemolytic levels.
MFN1032 has hrc RST genes
The lysis of RBCs by a number of bacteria requires the formation of a pore in the erythrocyte membrane by TTSS protein. To determine whether TTSS-like genes are present in MFN1032 and MF37, we used PCR primers targeting hrpU operon, (so called U operon of the hrp cluster of type I) encoding the conserved core proteins of fluorescent Pseudomonas TTSS, described by Mazurier et al. . The region amplified by these primers includes the 3'end of hrc R, hrc S and the 5'end of hrc T.
A single fragment of 0.9 kb was obtained for MFN1032 and MF37 and cloned with the pMOS kit. Fragments were sequenced by Genome Express (France). Sequences were registered in the Genbank database (accession number: EU811174 for MFN1032 and FJ694188 for MF37) and named "hrc operon", partial sequence. These sequences predict an 87 residues HrcS protein in these two strains.
Comparison of the MFN1032 HrcS sequence with other Hrc-like sequences
% Identity to HrcS
Putative type III secretion membrane protein RscS
P. fluorescens Pf-5
Flagellar biosynthesis protein FliQ
P. fluorescens MF37
P. fluorescens Pf0-1
Flagellar biosynthesis protein FliQ
P. fluorescens C7R12
Pseudomonas syringae pv. tomato str. DC3000
Type III secretion protein HrcS
Pseudomonas syringae pv. phaseolicola 1448A
Type III secretion component protein HrcS
Effect of disruption of the hrpU operon
Given the homology between hrcS and fliP, we investigated the potential role of hrc RST genes in flagellar synthesis. The effect of disrupting the hrpU operon in MFN1030 was measured in swimming mobility assays, as described in the methods. At 28°C, we observed no differences in swimming ability between MFN1032, MFN1030 and MFN1031 (Figure 7B), suggesting that disruption of this operon has no effect on flagella motility.
To our knowledge this is the first study to demonstrate cell-associated hemolytic activity in clinical isolates of a Pseudomonas fluorescens. P.fluorescens MFN1032 cell in exponential growth phase displayed hemolytic activity at 37°C, whereas no hemolytic activity was detected using MFN1032 supernatant. This hemolytic activity was thus dependent on the presence of MFN1032 cells. MFN1032 cells caused hemolysis of RBCs without requiring prior centrifugation to reduce the distance between bacterial and red cell membrane below a critical threshold. Such a centrifugation step has previously been shown to be necessary to induce the "contact-dependent" hemolytic activity displayed by several other bacteria, for example Yersinia , Shigella  and Pseudomonas aeruginosa . In contrast, "induced" hemolysis does not require close RBC-bacterial contact for enteropathogenic Escherichia coli EPEC, due to the long EspA (TTSS secreted protein) filaments that form a connection between bacteria and host cells for protein translocation [29, 30]. MFN1032 hemolytic activity was not strictly contact-dependent but depended on the presence of MFN1032 cells. We therefore propose the term "cell-associated" hemolytic activity.
This activity is independent of the secreted hemolytic activity previously described for this strain. For all tested conditions, we have previously demonstrated that secreted hemolytic activity only occurs at the end of the exponential growth phase . MFN1032 supernatants were not hemolytic at 37°C in vitro and hemolysis was maximal at 17°C. Cell-associated hemolysis measured here was maximal during the exponential growth phase and retrieved at 37°C. Moreover, a gacA mutant of MFN1032 (V1), for which several extracellular activities are impaired (including secreted hemolytic activity), showed increased cell-associated hemolytic activity. In psychrotrophic bacteria, most secreted enzymes are generally found at 17°C (critical temperature), whereas membrane-associated activities are enhanced with decreased generation time [6, 31]. Thus, the maximum expression of this new hemolytic activity at 28°C (optimal growth temperature) is consistent with a cell surface associated process.
This hemolytic activity is not common to all Pseudomonas fluorescens species. Indeed, we only observed significant cell-associated hemolysis in the clinical strains MFN1032 and MFY162 and not in the environmental strains tested. Although our panel of studied strains is limited and can not be considered as representative, the presence of this activity seems to be dependent on strain origin, i.e clinical source. Cell-associated hemolytic activity has been rarely observed in environmental strains. Nevertheless, two hemolytic strains showing such phenotype have been described for Plesiomonas shigelloides (former Pseudomonas) .
We amplified TTSS-like genes hrc RST from MFN1032 and MF37 cells while P.fluorescens PfO-1 and Pf5 strains [21, 33] lack the TTSS genes found in related pathogens or plant-associated bacteria. hrpU operon-like has previously been found in the P. fluorescens strains KD (phytoprotection strain) and SBW25 (biocontrol strain) [22, 34]. In one study of a group of fluorescent Pseudomonas, TTSS-like genes were detected in 75% of the phytopathogenic but only in 32% of the saprophytic strains tested . The presence of hrc RST genes is not systematically correlated to hemolytic activity. Indeed, P. fluorescens MF37 and C7R12 have similar hrc RST genes to MFN1032 but are not hemolytic. Thus, the presence of these genes does not strictly imply hemolytic function. Lysis is dependent upon the ability of TTSS translocator proteins to form a pore in the erythrocyte membrane causing hemoglobin leakage. The presence of these hrc RST genes does not necessarily result in the assembly of a functional TTSS. Some TTSS genes are absent from SBW25 and TTSS virulence genes in KD have been suggested to have been recently acquired horizontally from phytopathogenic bacteria and recycled for biocontrol function .
TTSS-dependent lysis of erythrocytes has been observed in a number of bacteria. Contact-dependent hemolysis assays have been used to identify the genes required for a functional Salmonella TTSS 1 . MFN1032 cell-associated hemolytic activity shares common features with TTSS-mediated hemolysis. The various mechanisms involved include formation of a pore with an estimated size of 2.4 to 3.2 nm, consistent with TTSS-hemolysis mechanism previously described by Dacheux for Pseudomonas aeruginosa . MFN1032 cells did not show this cell-associated hemolysis during the stationary growth phase. Previous studies have shown a negative effect of high cell density, through a RpoS-mediated mechanisms  or by quorum-sensing , on TTSS gene expression in Pseudomonas aeruginosa. We found increased hemolytic activity in the MFN1032 gacA mutant (V1). This result suggests that the Gac two-component system is a negative regulator of cell-associated hemolytic activity. Studies on TTSS regulation in Pseudomonas aeruginosa have demonstrated that the GacA response regulator inhibits TTSS function and that, in a gacA mutant, the TTSS effector ExoS is hypersecreted . Opposite, in Pseudomonas syringae, GacA is a positive regulator of the TTSS . The homology between MFN1032 genes and plant-associated TTSS genes is not in favour of a direct negative transcriptional regulation by the system Gac.
To investigate the potential role of TTSS in this hemolytic process, we constructed a mutant with hrpU operon disruption, MFN1030, in which hemolytic activity was severely impaired. Hemolysis was restored in revertant MFN1031 cells, with hemolytic activity levels similar to wild type. Thus, cell-associated hemolytic activity seems to require an intact hrpU operon. In contrast, hrpU operon disruption did not affect swimming motility, suggesting that hrpU operon is not involved in flagella biosynthesis. In MFN1030 the single homologue recombinaison event with PME3087-hrc RST would result in, at least, a lack of HrcT protein. In Pseudomonas cichorri, an insertion of transposon in hrc T was described as sufficient to lost virulence on eggplant . This large insertion in MFN1030 would have a polar effect on genes situated downstream this operon. In Pseudomonas fluorescens, hrcRST genes are highly conserved. Other genes of the hrpU operon, however, seem to vary considerably [22, 34]. PCR experiments based on SBW25 and KD sequences did not lead to an amplification of any hrc genes located downstream or upstream hrc RST (data not shown). An experiment of chromosome walking should allow us to identify these genes.
The hrcRST genes from Pseudomonas fluorescens MFN1032 show a high level of homology with hrcRST genes from Pseudomonas syringae, a plant pathogen. TTSS-dependent pore formation is due to the insertion of the translocation pores into host cell membranes. In Pseudomonas syringae, Hrpz psph forms pores in vitro and is exported by the TTSS. However, when introduced into Yersinia enterocolitica cells, this protein is exported via the Yersinia SSTT but cannot replace YopB functions and do not cause RBC hemolysis . HrpZ is unable to induce pore formation. Moreover, in the two strains of Pseudomonas fluorescens already described no hrp Z homologue was found. We tried to amplify this gene with primers design from hpr Z from other pseudomonad, but without success.
The nature of the TTSS component implicates in the cell hemolytic activity of MFN1032 remains to be determined. We will address this issue in future studies.
Pseudomonas fluorescens MFN1032 is a clinical strain isolate that displays two distinct types of hemolytic activity, described here for the first time. The first type is observed in the cell-free supernatant of rich media cultures at 28°C, whereas the second, cell-associated type of hemolysis, is detected at 37°C in the presence of erythrocytes. This strain has hrc RST genes, a feature that is not shared by all Pseudomonas fluorescens strains. Our study establishes an unexpected link between these hrc genes and cell-associated hemolytic activity. These initial findings are consistent, although not sufficient, to demonstrate that this cell-associated hemolysis is due to a functional TTSS. Investigation of type III effector genes in the genome of this strain and the construction of targeted mutants are now needed to confirm these findings. Nevertheless, this study suggests that certain strains of the highly heterogeneous species Pseudomonas fluorescens, which is usually considered to be a saprophytic species, express virulence with characteristic of pathogenic species belonging to the Pseudomonas genus. Nevertheless the principal role of this TTSS homologue to the one of plant-associated bacteria is probably not the pathogenicity against endotherms. The first target of this system would rather be unicellular eukaryotes of the rhizosphere, as mycetes or amoebas.
Bacterial strains and culture conditions
The MFN1032 strain was collected from a hospital patient suffering from pulmonary tract infection (expectoration) and was considered to be the cause of the infection. MFN1032 was identified as a Pseudomonas fluorescens biovar I strain  and was able to grow at 37°C.
CHA is a bronchopulmonary isolate of Pseudomonas aeruginosa from a cystic fibrosis patient . This strain induces TTSS-dependent but ExoU-independent oncosis of neutrophils and macrophages. CHA-induced macrophage death results from a pore forming activity that is dependent on the TTSS. Contact dependent hemolysis provoked by CHA requires the same pore forming activity. CHA has a well inducible and tightly regulated TTSS , and is used in our study as a positive control of RBC-TTSS hemolysis.
MF37 is a spontaneous rifampicin-resistant mutant of the MFO strain, a psychrotrophic strain of Pseudomonas fluorescens biovar V, isolated from raw milk and extensively studied in our laboratory .
MFY162 is a clinical isolate of Pseudomonas fluorescens Biovar I, MFY161 and MFY163 are clinical isolates of Pseudomonas mosselli  and C7R12 a Pseudomonas fluorescens psychrotrophic rhizospheric strain .
These bacteria were cultured in Luria Bertani medium (LB), at various temperatures between 8 and 37°C, with shaking at 180 rpm. When necessary, 20 μg/mL tetracycline or 100 μg/mL ampicillin was added. Bacterial density was determined by measuring optical density at 580 nm (Spectronic Unicam spectrophotometer).
Each strain was incubated on LB agar plates for 24 h at 28°C. Plates of LB medium solidified with 0.3% agar were inoculated by stabbing colonies with a toothpick and inserting the end of the toothpick just below the surface of the agar. Three colonies were picked from three plates and incubated at 28°C until a migration halo appeared.
Hemolysis was performed essentially as described by Dacheux . Sheep red blood cells (RBCs), obtained from Eurobio (France), were washed three times in PBS (pH 7.2, 0.8% NaCl, 0.02% KCl, 0.17% Na2HPO4, 0.8% KH2PO4) and resuspended in RPMI-1640 medium without pH indicator (Sigma) at a density of 5 × 108 RBCs mL-1 at 4°C. Bacteria were grown in LB to an OD580 nm of 0.7 - 1.5, centrifuged and resuspended in RPMI-1640 at 5 × 108 bacteria mL-1. Hemolysis assays were started by mixing 100 μL of RBCs and 100 μL of bacteria, which were than centrifuged at 1500 g or 400 g for 10 minutes and incubated at 37°C for 1 h. The release of hemoglobin was measured at 540 nm, after centrifugation, in 100 μL of cell supernatant.
The percentage (%) of total lysis was calculated as follows: % = [(X -B)/(T-B)] × 100, where B (baseline), a negative control, was corresponding to RBCs incubated with 100 μL of RPMI-1640, and T, a positive control, was corresponding to total RBCs lysis, obtained by incubating cells with 0.1% SDS. X is the OD value of the analysed sample.
When indicated, RBCs were resuspended in 60 mM sterile solutions of osmoprotectant in RPMI-1640, to give a final concentration of 30 mM. For these experiments, a control of hemoglobin precipitation in presence of PEG 4000 and PEG 3000 was realized . PEG 3000 or 4000 were added to a RBCs lysis supernatant obtained after incubation with MFN1032 at a final concentration of 30 mM. No variation of hemoglobin OD value was observed in our conditions during incubation at 37°C for 1 h.
Oligonucleotides and polymerase chain reactions
MFN1032 and MF37 strains were resuspended in 500 μL sterile ultrapure water. The suspension (2 μL) was then used for PCR amplification of DNA from bacterial colonies. PCR was carried out in a 25 μL reaction volume, in a GeneAmp PCR system 2400 (Perkin-Elmer Corporation, USA). Each reaction mixture contained DNA, 0.25 μL Taq polymerase (Q-Biogen, Illkrirch, France), 2.5 μL corresponding buffer, 2.5 μL primers (20 μM) and 2 μL deoxyribonucleoside triphosphate (2.5 mM). After initial denaturation for three minutes at 95°C, the reaction mixture was subjected to 35 cycles of 1 minute at 94°C, 1 minute at 41°C and two minutes at 72°C, followed by a final 3 minutes extension at 72°C. PCR primers, HRCR8092 (5'-CCITT(C/T)ATCGT(C/T)AT(C/T)GA(C/T)(C/T)T-3') and HRCT8986 (5'-CTGTCCCAGATIAICTGIGT-3') (where I indicates inosine), synthesized by Eurogentec (Angers, France), were designed to amplify the "hrc operon", a region of operon U of the hrp cluster of type I (hrpU operon), including the 3' end of hrc R (26%), hrc S (100%), and the 5' end of hrc T (42%) (approximately 897 bp) .
Aliquots (5 μL) of the PCR products were analyzed by electrophoresis in 1% agarose gels, stained with ethidium bromide and photographed under UV illumination.
Cloning and sequencing the hrc RST PCR fragment
PCR products were cloned with the pMOSBlue blunt-ended cloning kit (Amersham/Biosciences). MOS cells were transformed and, after blue/white colony screening, clones were picked and plasmid DNA was isolated with the QIAprep Spin Miniprep Kit (Qiagen).
The PCR products were sequenced by Genome Express (France). The predicted sequences of MFN1032 hrc RST and MF37 hrc RST were submitted for BLAST queries http://www.ncbi.nlm.nih.gov/BLAST/.
Construction of MFN1030, an hrc U operon-disrupted mutant of MFN1032 and MF1031, its revertant
The hrc RST-pMOS plasmid from MFN1032 was digested with Eco RI/Hind III and subsequently hrc RST fragment was inserted into the transferable suicide plasmid pME3087 (6,9 Kb) digested by the same enzymes . This construction, pME3087-hrc RST (7,8 kb), was then introduced into Escherichia coli DH5α MCR cells by electroporation. Plasmids were isolated using the QIAprep Spin Miniprep Kit (Qiagen), checked by digestion with Hind III/Eco RI and transferred into the Escherichia coli conjugative strain S17.1 . Colonies were selected for their resistance to tetracycline (20 μg/mL). MFN1032 (naturally ampicillin resistant) cells were conjugated with S17.1 cells carrying the pME3087-hrc RST plasmid and strains were selected for their resistance to tetracycline (20 μg/mL) and ampicillin (100 μg/mL) that corresponds to insertion of the whole plasmid via a single homologue recombinaison. One of the clones was selected and corresponded to an hrpU operon disruption mutant. This disruption mutant was called MFN1030. The reversion of the mutant MFN1030 was obtained after incubating MFN1030 cells on an LB agar plate for 72 hours. Of all the colonies obtained, 100 were subcultured in parallel on LB agar plates with or without tetracycline (20 μg/mL).
Colonies growing on LB agar plates without tetracycline but not on LB agar plates with tetracycline (20 μg/mL) reflect a second recombination event and an excision of the plasmid. One clone was selected and named MFN1031, a revertant of MFN1030 strain.
The Région Haute-Normandie supported this work. We thank Magalie Barreau for technical help.
- Couillerot O, Prigent-Combaret C, Caballero-Mellado J, Moenne-Loccoz Y: Pseudomonas fluorescens and closely-related fluorescent pseudomonads as biocontrol agents of soil-borne phytopathogens. Lett Appl Microbiol. 2009, 48 (5): 505-512. 10.1111/j.1472-765X.2009.02566.x.View ArticlePubMed
- Tourkya B, Boubellouta T, Dufour E, Leriche F: Fluorescence spectroscopy as a promising tool for a polyphasic approach to pseudomonad taxonomy. Curr Microbiol. 2009, 58 (1): 39-46. 10.1007/s00284-008-9263-0.View ArticlePubMed
- Bodilis J, Calbrix R, Guerillon J, Merieau A, Pawlak B, Orange N, Barray S: Phylogenetic relationships between environmental and clinical isolates of Pseudomonas fluorescens and related species deduced from 16S rRNA gene and OprF protein sequences. Syst Appl Microbiol. 2004, 27 (1): 93-108. 10.1078/0723-2020-00253.View ArticlePubMed
- Meyer JM, Geoffroy VA, Baida N, Gardan L, Izard D, Lemanceau P, Achouak W, Palleroni NJ: Siderophore typing, a powerful tool for the identification of fluorescent and nonfluorescent pseudomonads. Appl Environ Microbiol. 2002, 68 (6): 2745-2753. 10.1128/AEM.68.6.2745-2753.2002.PubMed CentralView ArticlePubMed
- Burini JF, Gugi B, Merieau A, Guespin-Michel JF: Lipase and acidic phosphatase from the psychrotrophic bacterium Pseudomonas fluorescens: two enzymes whose synthesis is regulated by the growth temperature. FEMS Microbiol Lett. 1994, 122 (1-2): 13-18. 10.1111/j.1574-6968.1994.tb07136.x.View ArticlePubMed
- Gugi B, Orange N, Hellio F, Burini JF, Guillou C, Leriche F, Guespin-Michel JF: Effect of growth temperature on several exported enzyme activities in the psychrotrophic bacterium Pseudomonas fluorescens. J Bacteriol. 1991, 173 (12): 3814-3820.PubMed CentralPubMed
- Picot L, Abdelmoula SM, Merieau A, Leroux P, Cazin L, Orange N, Feuilloley MG: Pseudomonas fluorescens as a potential pathogen: adherence to nerve cells. Microbes Infect. 2001, 3 (12): 985-995. 10.1016/S1286-4579(01)01462-9.View ArticlePubMed
- Feuilloley MGJ, Mezghani-Abdelmoula S, Picot L, Lesouhaitier O, Merieau A, Guerillon J, Orange N: Involvement of Pseudomonas and related species in central nervous system infections. Recent Adv Dev Microbiol. 2003, 7: 55-71.
- Picot L, Mezghani-Abdelmoula S, Chevalier S, Merieau A, Lesouhaitier O, Guerillon J, Cazin L, Orange N, Feuilloley MG: Regulation of the cytotoxic effects of Pseudomonas fluorescens by growth temperature. Res Microbiol. 2004, 155 (1): 39-46. 10.1016/j.resmic.2003.09.014.View ArticlePubMed
- Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, Guerillon J, Meyer JM, Orange N, Feuilloley MG: Comparative study of 7 fluorescent pseudomonad clinical isolates. Can J Microbiol. 2008, 54 (1): 19-27. 10.1139/W07-110.View ArticlePubMed
- Rossignol G, Merieau A, Guerillon J, Veron W, Lesouhaitier O, Feuilloley MG, Orange N: Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol. 2008, 8: 189-10.1186/1471-2180-8-189.PubMed CentralView ArticlePubMed
- Rossignol G, Sperandio D, Guerillon J, Duclairoir Poc C, Soum-Soutera E, Orange N, Feuilloley MG, Merieau A: Phenotypic variation in the Pseudomonas fluorescens clinical strain MFN1032. Res Microbiol. 2009, 160 (5): 337-344. 10.1016/j.resmic.2009.04.004.View ArticlePubMed
- Barbieri JT, Sun J: Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol. 2004, 152: 79-92. full_text.PubMed
- Frank DW: The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol. 1997, 26 (4): 621-629. 10.1046/j.1365-2958.1997.6251991.x.View ArticlePubMed
- Vallis AJ, Yahr TL, Barbieri JT, Frank DW: Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions. Infect Immun. 1999, 67 (2): 914-920.PubMed CentralPubMed
- Galan JE, Collmer A: Type III secretion machines: bacterial devices for protein delivery into host cells. Science. 1999, 284 (5418): 1322-1328. 10.1126/science.284.5418.1322.View ArticlePubMed
- Huynh TV, Dahlbeck D, Staskawicz BJ: Bacterial blight of soybean: regulation of a pathogen gene determining host cultivar specificity. Science. 1989, 245 (4924): 1374-1377. 10.1126/science.2781284.View ArticlePubMed
- Huang HC, He SY, Bauer DW, Collmer A: The Pseudomonas syringae pv. syringae 61 hrpH product, an envelope protein required for elicitation of the hypersensitive response in plants. J Bacteriol. 1992, 174 (21): 6878-6885.PubMed CentralPubMed
- Lee J, Klusener B, Tsiamis G, Stevens C, Neyt C, Tampakaki AP, Panopoulos NJ, Noller J, Weiler EW, Cornelis GR: HrpZ(Psph) from the plant pathogen Pseudomonas syringae pv. phaseolicola binds to lipid bilayers and forms an ion-conducting pore in vitro. Proc Natl Acad Sci USA. 2001, 98 (1): 289-294. 10.1073/pnas.011265298.PubMed CentralPubMed
- Preston GM, Bertrand N, Rainey PB: Type III secretion in plant growth-promoting Pseudomonas fluorescens SBW25. Mol Microbiol. 2001, 41 (5): 999-1014. 10.1046/j.1365-2958.2001.02560.x.View ArticlePubMed
- Ma Q, Zhai Y, Schneider JC, Ramseier TM, Saier MH: Protein secretion systems of Pseudomonas aeruginosa and P fluorescens. Biochim Biophys Acta. 2003, 1611 (1-2): 223-233. 10.1016/S0005-2736(03)00059-2.View ArticlePubMed
- Rezzonico F, Binder C, Defago G, Moenne-Loccoz Y: The type III secretion system of biocontrol Pseudomonas fluorescens KD targets the phytopathogenic Chromista Pythium ultimum and promotes cucumber protection. Mol Plant Microbe Interact. 2005, 18 (9): 991-1001. 10.1094/MPMI-18-0991.View ArticlePubMed
- Mazurier SLM, Siblot S, Mougel C, Lemanceau P: Distribution and diversity of type III secretion system-like genes in saprophytic and phytopathogenic fluorecent Pseudomonas. FEMS Microbiology Ecology. 2004, 49: 455-467. 10.1016/j.femsec.2004.04.019.View ArticlePubMed
- Toussaint B, Delic-Attree I, Vignais PM: Pseudomonas aeruginosa contains an IHF-like protein that binds to the algD promoter. Biochem Biophys Res Commun. 1993, 196 (1): 416-421. 10.1006/bbrc.1993.2265.View ArticlePubMed
- Dacheux D, Goure J, Chabert J, Usson Y, Attree I: Pore-forming activity of type III system-secreted proteins leads to oncosis of Pseudomonas aeruginosa-infected macrophages. Mol Microbiol. 2001, 40 (1): 76-85. 10.1046/j.1365-2958.2001.02368.x.View ArticlePubMed
- Broek van den D, Chin AWTF, Bloemberg GV, Lugtenberg BJ: Molecular nature of spontaneous modifications in gacS which cause colony phase variation in Pseudomonas sp. strain PCL1171. J Bacteriol. 2005, 187 (2): 593-600. 10.1128/JB.187.2.593-600.2005.PubMed CentralView ArticlePubMed
- Hakansson S, Schesser K, Persson C, Galyov EE, Rosqvist R, Homble F, Wolf-Watz H: The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity. Embo J. 1996, 15 (21): 5812-5823.PubMed CentralPubMed
- Clerc P, Baudry B, Sansonetti PJ: Plasmid-mediated contact haemolytic activity in Shigella species: correlation with penetration into HeLa cells. Ann Inst Pasteur Microbiol. 1986, 137A (3): 267-278. 10.1016/S0769-2609(86)80033-3.View ArticlePubMed
- Shaw RK, Daniell S, Ebel F, Frankel G, Knutton S: EspA filament-mediated protein translocation into red blood cells. Cell Microbiol. 2001, 3 (4): 213-222. 10.1046/j.1462-5822.2001.00105.x.View ArticlePubMed
- Crepin VF, Martinez E, Shaw RK, Frankel G, Daniell SJ: Structural and functional properties of chimeric EspA-FliCi filaments of EPEC. J Mol Biol. 2008, 378 (1): 243-250. 10.1016/j.jmb.2008.02.042.View ArticlePubMed
- Merieau A, Gügi B, Guespin-Michel JF, Orange N: Temperature regulation of lipase secretion by Pseudomonas fluorescens strain MF0. Appl Microbiol Biotechnol. 1993, 39: 104-109.View Article
- Gonzalez-Rodriguez N, Santos JA, Otero A, Garcia-Lopez ML: Cell-associated hemolytic activity in environmental strains of Plesiomonas shigelloides expressing cell-free, iron-influenced extracellular hemolysin. J Food Prot. 2007, 70 (4): 885-890.PubMed
- Paulsen IT, Press CM, Ravel J, Kobayashi DY, Myers GS, Mavrodi DV, DeBoy RT, Seshadri R, Ren Q, Madupu R: Complete genome sequence of the plant commensal Pseudomonas fluorescens Pf-5. Nat Biotechnol. 2005, 23 (7): 873-878. 10.1038/nbt1110.View ArticlePubMed
- Vinatzer BA, Jelenska J, Greenberg JT: Bioinformatics correctly identifies many type III secretion substrates in the plant pathogen Pseudomonas syringae and the biocontrol isolate P. fluorescens SBW25. Mol Plant Microbe Interact. 2005, 18 (8): 877-888. 10.1094/MPMI-18-0877.View ArticlePubMed
- Field TR, Layton AN, Bispham J, Stevens MP, Galyov EE: Identification of novel genes and pathways affecting Salmonella type III secretion system 1 using a contact-dependent hemolysis assay. J Bacteriol. 2008, 190 (9): 3393-3398. 10.1128/JB.01189-07.PubMed CentralView ArticlePubMed
- Hogardt M, Roeder M, Schreff AM, Eberl L, Heesemann J: Expression of Pseudomonas aeruginosa exoS is controlled by quorum sensing and RpoS. Microbiology. 2004, 150 (Pt 4): 843-851. 10.1099/mic.0.26703-0.View ArticlePubMed
- Bleves S, Soscia C, Nogueira-Orlandi P, Lazdunski A, Filloux A: Quorum sensing negatively controls type III secretion regulon expression in Pseudomonas aeruginosa PAO1. J Bacteriol. 2005, 187 (11): 3898-3902. 10.1128/JB.187.11.3898-3902.2005.PubMed CentralView ArticlePubMed
- Soscia C, Hachani A, Bernadac A, Filloux A, Bleves S: Cross talk between type III secretion and flagellar assembly systems in Pseudomonas aeruginosa. J Bacteriol. 2007, 189 (8): 3124-3132. 10.1128/JB.01677-06.PubMed CentralView ArticlePubMed
- Chatterjee A, Cui Y, Yang H, Collmer A, Alfano JR, Chatterjee AK: GacA, the response regulator of a two-component system, acts as a master regulator in Pseudomonas syringae pv. tomato DC3000 by controlling regulatory RNA, transcriptional activators, and alternate sigma factors. Mol Plant Microbe Interact. 2003, 16 (12): 1106-1117. 10.1094/MPMI.2003.16.12.1106.View ArticlePubMed
- Hojo H, Koyanagi M, Tanaka M, Kajihara S, Ohnishi K, Kiba A, Hikichi Y: The hrp genes of Pseudomonas cichorii are essential for pathogenicity on eggplant but not on lettuce. Microbiology. 2008, 154 (Pt 10): 2920-2928. 10.1099/mic.0.2008/021097-0.PubMed CentralView ArticlePubMed
- Filopon D, Merieau A, Bernot G, Comet JP, Leberre R, Guery B, Polack B, Guespin-Michel J: Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa. BMC Bioinformatics. 2006, 7: 272-10.1186/1471-2105-7-272.PubMed CentralView ArticlePubMed
- Mirleau P, Delorme S, Philippot L, Meyer J, Mazurier S, Lemanceau P: Fitness in soil and rhizosphere of Pseudomonas fluorescens C7R12 compared with a C7R12 mutant affected in pyoverdine synthesis and uptake. FEMS Microbiol Ecol. 2000, 34 (1): 35-44. 10.1111/j.1574-6941.2000.tb00752.x.View ArticlePubMed
- Quijano JC, Lemeshko VV: Hemoglobin precipitation by polyethylene glycols leads to underestimation of membrane pore sizes. Biochim Biophys Acta. 2008, 1778 (12): 2775-2780. 10.1016/j.bbamem.2008.07.009.View ArticlePubMed
- Schnider U, Keel C, Voisard C, Defago G, Haas D: Tn5-directed cloning of pqq genes from Pseudomonas fluorescens CHA0: mutational inactivation of the genes results in overproduction of the antibiotic pyoluteorin. Appl Environ Microbiol. 1995, 61 (11): 3856-3864.PubMed CentralPubMed
- Simon RPU, Pehle A: A broad host range mobilization system for in vitro genetic engineering: transposon mutagenesis in Gram-negative bacteria. biotechology. 1983, 1: 784-790. 10.1038/nbt1183-784.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.